Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2894)
All Articles published online
|
Jul 15, 2003 (publication date) through Aug 7, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chu CH, Lin SC, Shih SC, Kao CR, Chou SY. Fatty metamorphosis of the liver in patients with breast cancer: Possible associated factors. World J Gastroenterol 2003; 9(7): 1618-1620 [PMID: 12854178 DOI: 10.3748/wjg.v9.i7.1618] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i7/1618.htm |
| Number | Citing Articles |
| 1 |
Namrata Joshi, Pankaj Kumar, Shiwakshi Sharma, Remya Jayakumar, Anand Mishra, V. Harsha, Manoj Kumar Dash. Swarna Bhasma reduces the blood concentration of tumor-specific signatures and protects from hepatocellular damages in Ehrlich ascites mice model. Journal of Ayurveda and Integrative Medicine 2025; 16(5): 101152 doi: 10.1016/j.jaim.2025.101152
|
| 2 |
Chien-Liang Liu, Jon-Kway Huang, Shih-Ping Cheng, Yuan-Ching Chang, Jie-Jen Lee, Tsang-Pai Liu. Fatty liver and transaminase changes with adjuvant tamoxifen therapy. Anti-Cancer Drugs 2006; 17(6): 709 doi: 10.1097/01.cad.0000215056.47695.92
|
| 3 |
Tom Saphner, Shirley Triest‐Robertson, Hailun Li, Paul Holzman. The association of nonalcoholic steatohepatitis and tamoxifen in patients with breast cancer. Cancer 2009; 115(14): 3189 doi: 10.1002/cncr.24374
|
| 4 |
Omar T. Ahmed, Alina M. Allen. Extrahepatic Malignancies in Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 2019; 18(4): 455 doi: 10.1007/s11901-019-00499-5
|
| 5 |
Payam Izadpanahi, Mahyar Mohammadifard, Tahmine Tavakoli, Najmeh Abbasi, Seyed Alireza Javadinia. Effect of Chemotherapy on Fatty Liver Occurrence in Breast and Gastrointestinal Cancer Patients: A Case-Controlled Study. Hepatitis Monthly 2020; 20(3) doi: 10.5812/hepatmon.97986
|
| 6 |
Brent A. Neuschwander-Tetri. Zakim and Boyer's Hepatology. 2006; : 1031 doi: 10.1016/B978-1-4160-3258-8.50060-7
|
| 7 |
Maryam K. Ibrahim, Tracey G. Simon, Mary E. Rinella. Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2023; 27(2): 251 doi: 10.1016/j.cld.2023.01.004
|
| 8 |
Reza Hakkak, Ahmed Al-Dwairi, George J. Fuchs, Soheila Korourian, Frank A. Simmen. Dietary soy protein induces hepatic lipogenic enzyme gene expression while suppressing hepatosteatosis in obese female Zucker rats bearing DMBA-initiated mammary tumors. Genes & Nutrition 2012; 7(4): 549 doi: 10.1007/s12263-012-0294-6
|
| 9 |
Nirmala G. Sannappa Gowda, Varsha D. Shiragannavar, Samudyata C. Prabhuswamimath, Sunanda Tuladhar, Saravana Babu Chidambaram, Prasanna K. Santhekadur. Ehrlich Ascites carcinoma mice model for studying liver inflammation and fibrosis. Advances in Cancer Biology - Metastasis 2022; 4: 100029 doi: 10.1016/j.adcanc.2022.100029
|
| 10 |
Yoshinari Ogawa, Katsumi Ikeda, Tetsuo Izumi, Shiho Okuma, Makoto Ichiki, Tetsuro Ikeya, Jyunya Morimoto, Yukio Nishiguchi, Teruyuki Ikehara. First indicators of relapse in breast cancer: evaluation of the follow-up program at our hospital. International Journal of Clinical Oncology 2013; 18(3): 447 doi: 10.1007/s10147-012-0401-0
|